Efficacy and Tolerability of Calcitonin Gene-Related Peptide Targeted Monoclonal Antibody Medications as Add-on Therapy to OnabotulinumtoxinA in Patients with Chronic Migraine.
Sign Up to like & getrecommendations! Published in 2021 at "Pain medicine"
DOI: 10.1093/pm/pnab093
Abstract: BACKGROUND We examined the efficacy and tolerability of calcitonin gene-related peptide targeted monoclonal antibodies (CGRP-targeted mAbs) as add-on therapy for patients with chronic migraine (CM) undergoing treatment with onabotulinumtoxinA(onabot) who require additional preventive therapy. METHODS… read more here.
Keywords: cgrp targeted; targeted mab; tolerability; tolerability calcitonin ... See more keywords
Revolutionizing migraine management: advances and challenges in CGRP-targeted therapies and their clinical implications
Sign Up to like & getrecommendations! Published in 2024 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2024.1402569
Abstract: Migraine, a prevalent neurological disorder, affects approximately 14.1% of the global population and disproportionately impacts females. This debilitating condition significantly compromises quality of life, productivity, and incurs high healthcare costs, presenting a challenge not only… read more here.
Keywords: cgrp targeted; revolutionizing migraine; migraine management; advances challenges ... See more keywords